Items where Author or Contributor is "Angelis, Aris"
 | Up a level |
Number of items: 6.
2022
Angelis, A;
Mellerio, JE;
Kanavos, P;
(2022)
Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.
Orphanet journal of rare diseases, 17 (1).
p. 346.
ISSN 1750-1172
DOI: https://doi.org/10.1186/s13023-022-02419-1
Angelis, Aris;
Suarez Alonso, Carlos;
Kyriopoulos, Ilias;
Mossialos, Elias;
(2022)
Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non-COVID-19 Indications, 2020-2021.
Jama Network Open, 5 (8).
e2226892-.
ISSN 2574-3805
DOI: https://doi.org/10.1001/jamanetworkopen.2022.26892
2021
Abou-El-Enein, Mohamed;
Angelis, Aris;
Appelbaum, Frederick R;
Andrews, Nancy C;
Bates, Susan E;
Bierman, Arlene S;
Brenner, Malcolm K;
Cavazzana, Marina;
Caligiuri, Michael A;
Clevers, Hans;
+25 more...
Cooke, Emer;
Daley, George Q;
Dzau, Victor J;
Ellis, Lee M;
Fineberg, Harvey V;
Goldstein, Lawrence SB;
Gottschalk, Stephen;
Hamburg, Margaret A;
Ingber, Donald E;
Kohn, Donald B;
Krainer, Adrian R;
Maus, Marcela V;
Marks, Peter;
Mummery, Christine L;
Pettigrew, Roderic I;
Rutter, Joni L;
Teichmann, Sarah A;
Terzic, Andre;
Urnov, Fyodor D;
Williams, David A;
Wolchok, Jedd D;
Lawler, Mark;
Turtle, Cameron J;
Bauer, Gerhard;
Ioannidis, John PA;
(2021)
Evidence generation and reproducibility in cell and gene therapy research: A call to action.
Molecular therapy. Methods & clinical development, 22.
pp. 11-14.
ISSN 2329-0501
DOI: https://doi.org/10.1016/j.omtm.2021.06.012
Angelis, Aris;
Darrow, Jonathan;
(2021)
Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
Vaccine, 39 (17).
pp. 2328-2330.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2021.03.053
2020
Angelis, Aris;
Phillips, Lawrence D;
(2020)
Advancing structured decision-making in drug regulation at the FDA and EMA.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 87 (2).
pp. 395-405.
ISSN 0306-5251
DOI: https://doi.org/10.1111/bcp.14425
Angelis, Aris;
Thursz, Mark;
Ratziu, Vlad;
O'Brien, Alastair;
Serfaty, Lawrence;
Canbay, Ali;
Schiefke, Ingolf;
Costa, Joao Bana E;
Lecomte, Pascal;
Kanavos, Panos;
(2020)
Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.
MEDICAL DECISION MAKING, 40 (6).
pp. 830-845.
ISSN 0272-989X
DOI: https://doi.org/10.1177/0272989X20940672